Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

BACKGROUND: Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would be useful for clinical practice and policy decision-making on allocating resour...

Descripción completa

Detalles Bibliográficos
Autores principales: Turongkaravee, Saowalak, Jittikoon, Jiraphun, Rochanathimoke, Onwipa, Boyd, Kathleen, Wu, Olivia, Chaikledkaew, Usa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487501/
https://www.ncbi.nlm.nih.gov/pubmed/34600523
http://dx.doi.org/10.1186/s12913-021-07025-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487501/
https://www.ncbi.nlm.nih.gov/pubmed/34600523
http://dx.doi.org/10.1186/s12913-021-07025-8

Ejemplares similares